期刊文献+

FK228抑制鼠视网膜新生血管的机制研究 被引量:1

The mechanism research of inhibitory effects of FK228 on retinal neovascularization
下载PDF
导出
摘要 目的:探讨组蛋白去乙酰化酶抑制剂(Histone deacetylase inhibitor,HDACI)FK228抑制视网膜新生血管形成的机制。方法:将鼠龄为7d的C57BL/6J幼鼠置于75%浓度的氧环境中连续生活5d,建立髙氧诱导的血管增生性视网膜病变幼鼠模型。随机分为正常对照组、给氧对照组及治疗组(幼鼠玻璃体腔内注射FK228250ng,对侧眼注射相同体积的二甲基亚砜溶液作为对照)。并采用免疫组织化学法检测缺氧诱导因子α亚基(Hypoxia-inducible factor-1α,HIF-1α)和血管内皮细胞生长因子(Vascular endothelial growth factor,VEGF),观察FK228抑制视网膜新生血管的机制。结果:(1)空白组和治疗组的HIF-1α免疫细胞阳性率没有明显差异(P>0.05)。对照组与空白组和治疗组这两组的HIF-1α免疫细胞阳性率均有明显差异(P<0.05)。(2)空白组和治疗组的VEGF免疫细胞阳性率没有明显差异(P>0.05)。对照组与空白组和治疗组这两组的VEGF免疫细胞阳性率均有明显差异(P<0.05)。结论:FK228抑制视网膜新生血管形成的机制可能与其抑制HIF-1α活性从而下调VEGF的表达有关。 Objective:To explore the mechanism of the inhibitory effects of FK228 on retinal nevoascularization. Methods: One-week-old C57BL/6J mice were put into the environment with 75% oxygen for 5 days to establish models of vascular proliferation retinopathy. These mice were divided into normal control,high oxygen control and treatment groups(One eye of each mouse received an intravitreal injection of 250ng of FK228,and the same volume of DMSO(dimethylsuffoxide) was injected into the other eye of the mice both in these two groups as a control). Hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor( VEGF )expression were examined by immunohistochemistry. The inhibitory effects of FK228 on retinal nevoascularization were evaluated. Results:(1 )There was no significant difference in HIF-1 ctpositive rate between normal group and treatment group(P〉0.05);HIF-1α positive rate of control groups was higher than that in normal group and treatment group with significant difference among them(P〈0.05 ).( 2)There was no significant difference in VEGF positive rate between normal group and treatment group(P〉0.05);VEGF positive rate in control groups was higher than that in normal group and treatment group with significant difference among them(P〈0.05 ). Conclusions:The mechanism of inhibitory effects of FK228 on retinal neovascularization is associated with the fact that FK228 inhibits activities of HIF-1α and deduce number of VEGF.
出处 《重庆医科大学学报》 CAS CSCD 2008年第7期807-810,共4页 Journal of Chongqing Medical University
基金 重庆市科技项目[2004]54号
关键词 组蛋白去乙酰化酶抑制剂 视网膜新生血管 HIF-1Α VEGF Histone deacetylase inhibitor Retinal neovascularization Hypoxia-inducible factor-1α (HIF-1α) Vascular endothelial growth factor(VEGF)
  • 相关文献

参考文献7

  • 1Mie LY,Kim SH,Kim HS,et al. Inhibition of hypoxia-induced angiogenesis by FK228,a specific histone deacetylase inhibitor,via suppression of HIF-1 α activity[J]. Biochem Biophys Res Commun, 2003 ; 300( 1 ) : 241-246.
  • 2Kosugi H,lot M,Yamamoto Y,et al. In vivo effect of a histone deacetylase inhibitor,FK228,on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice[J]. Jpn J Cancer Res,2001 ;92(5):529- 536.
  • 3Cress WD,Seto E. Histone deacetylases,transcriptional control, and cancer[J]. Cell Physiol,2000; 184( 1 ): 1-16.
  • 4Shima DT,Gougos A,Miller JW,et al. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of maraca fascicularis[J]. Invest Ophthal Vis Sci, 1996;37(7): 1334-1340.
  • 5Malecaze F,Clamens S,Simorre-Pinatel V,et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy[J]. Arch Ophthal, 1994 ; 112( 11 ) : 1476-1482.
  • 6叶红,金咸瑢.低氧诱导因子-1的结构、功能、调节及其与低氧信号转导的关系[J].生理科学进展,2001,32(1):62-64. 被引量:24
  • 7Damert A,Ikeda E,Risau W. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells[J]. Biochem J, 1997 ; 327 (2) :419-423.

二级参考文献4

共引文献23

同被引文献11

  • 1Blanchard F, Chipoy C. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases[J].Drug Discov Today,2005,10( 3 ) : 197-204.
  • 2Abraham E,Singer M. Mechanisms of sepsis-induced organ dysfunction[J]. Crit Care Med, 2007,35 (10) : 2408-2416.
  • 3Rittirsch D, Huber-Lang M S, Flierl M A, et al. Immunodesign of experimental sepsis by cecal ligation and puncture[J]. Nat Protoe, 2009,4 (1):31-36.
  • 4Mehnert J M, Kelly W K. Histone deacetylase inhibitors : biology and mechanism of action[J]. Cancer J, 2007,13 ( 1 ) : 23-29.
  • 5Lin H S, Hu C Y, Chan H Y, et al. Anti-rheumatic activities of histone deacetylase ( HDAC ) inhibitors in vivo in collagen-induced arthritis in rodents[J]. Br J Pharmacol, 2007,150(7 ) : 862-872.
  • 6Glauben R, Batra A, Fedke L, et al. Histone hyperacetylation is asso- ciated with amelioration of experimental colitis in mice[J].J Immunol,2006, 176(8 ) : 5015-5022.
  • 7Chen LF,Fischle W, Verdin E, et al. Duration of nuclear NF-kappa B action regulated by reversible acetylation[J].Science, 2001,293 ( 5535 ) :1653-1657.
  • 8Chen L F, Greene W C. Regulation of distinct biological activities c the NF-kappaB transcription factor complex by acetylation[J]. J Mol Med 2003,81 (9) : 549-557.
  • 9Cao W,Bao C,Padalko E,et al. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling[J]. J Exp Med, 2008,205(6) : 1491-1503.
  • 10Adcock I M,Tsaprouni L,Bhavsar P, et al. Epigenetic regulation of airway inflammation[J]. Curr Opin Immunol, 2007,19(6 ) : 694-700.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部